Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
CBT 200 Gains 44 Points. More details...
CBT 200 Finishes With 15 Point Gain. More details...
CBT 200 Falls 24 Points. More details...
Makes Herbal Drugs In Modern Form. More details...
CBT 200 Moves Only A Point. More details...
CBT 200 Gains 24 Points. More details...
It Seems like a Natural Combination, But Will It Happen?...
Second Quarter Reports Are Solid Last week saw the very...
The third of the panels held at ChinaBio® Day, held...
For the first time in its 29 years, the J.P. Morgan...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
